Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury

Shih Hwa Chiou, Chih Hung Chiang, Ching Chih Chang, Hui Chun Huang, Yi Jen Chen, Ping Hsing Tsai, Shaw Yeu Jeng, Shuen Iu Hung, Jung Hung Hsieh, Hsu Shan Huang, Fa Yauh Lee, Shou Dong Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To date liver transplantation is the only effective treatment for end-stage liver diseases. Considering the potential of pluripotency and differentiation into tridermal lineages, induced pluripotent stem cells (iPSCs) may serve as an alternative of cell-based therapy. Herein, we investigated the effect of iPSC transplantation on thioacetamide- (TAA-) induced acute/fulminant hepatic failure (AHF) in mice. Firstly, we demonstrated that iPSCs had the capacity to differentiate into hepatocyte-like cells (iPSC-Heps) that expressed various hepatic markers, including albumin, -fetoprotein, and hepatocyte nuclear factor-3, and exhibited biological functions. Intravenous transplantation of iPSCs effectively reduced the hepatic necrotic area, improved liver functions and motor activity, and rescued TAA-treated mice from lethal AHF. 1,1 ′ -dioctadecyl-3,3, 3 ′,3 ′ -tetramethylindocarbocyanine perchlorate cell labeling revealed that iPSCs potentially mobilized to the damaged liver area. Taken together, iPSCs can effectively rescue experimental AHF and represent a potentially favorable cell source of cell-based therapy.

Original languageEnglish
Article number219060
JournalJournal of Biomedicine and Biotechnology
Volume2011
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Acute Liver Failure
Liver
Wounds and Injuries
Thioacetamide
Cell- and Tissue-Based Therapy
Hepatocyte Nuclear Factors
Fetal Proteins
End Stage Liver Disease
Stem Cell Transplantation
Liver Transplantation
Labeling
Hepatocytes
Albumins
Motor Activity
Transplantation

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Genetics
  • Molecular Biology
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Cite this

Chiou, S. H., Chiang, C. H., Chang, C. C., Huang, H. C., Chen, Y. J., Tsai, P. H., ... Lee, S. D. (2011). Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. Journal of Biomedicine and Biotechnology, 2011, [219060]. https://doi.org/10.1155/2011/219060

Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. / Chiou, Shih Hwa; Chiang, Chih Hung; Chang, Ching Chih; Huang, Hui Chun; Chen, Yi Jen; Tsai, Ping Hsing; Jeng, Shaw Yeu; Hung, Shuen Iu; Hsieh, Jung Hung; Huang, Hsu Shan; Lee, Fa Yauh; Lee, Shou Dong.

In: Journal of Biomedicine and Biotechnology, Vol. 2011, 219060, 2011.

Research output: Contribution to journalArticle

Chiou, SH, Chiang, CH, Chang, CC, Huang, HC, Chen, YJ, Tsai, PH, Jeng, SY, Hung, SI, Hsieh, JH, Huang, HS, Lee, FY & Lee, SD 2011, 'Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury', Journal of Biomedicine and Biotechnology, vol. 2011, 219060. https://doi.org/10.1155/2011/219060
Chiou, Shih Hwa ; Chiang, Chih Hung ; Chang, Ching Chih ; Huang, Hui Chun ; Chen, Yi Jen ; Tsai, Ping Hsing ; Jeng, Shaw Yeu ; Hung, Shuen Iu ; Hsieh, Jung Hung ; Huang, Hsu Shan ; Lee, Fa Yauh ; Lee, Shou Dong. / Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. In: Journal of Biomedicine and Biotechnology. 2011 ; Vol. 2011.
@article{484c48bc87b04376aec3f26f2377cce6,
title = "Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury",
abstract = "To date liver transplantation is the only effective treatment for end-stage liver diseases. Considering the potential of pluripotency and differentiation into tridermal lineages, induced pluripotent stem cells (iPSCs) may serve as an alternative of cell-based therapy. Herein, we investigated the effect of iPSC transplantation on thioacetamide- (TAA-) induced acute/fulminant hepatic failure (AHF) in mice. Firstly, we demonstrated that iPSCs had the capacity to differentiate into hepatocyte-like cells (iPSC-Heps) that expressed various hepatic markers, including albumin, -fetoprotein, and hepatocyte nuclear factor-3, and exhibited biological functions. Intravenous transplantation of iPSCs effectively reduced the hepatic necrotic area, improved liver functions and motor activity, and rescued TAA-treated mice from lethal AHF. 1,1 ′ -dioctadecyl-3,3, 3 ′,3 ′ -tetramethylindocarbocyanine perchlorate cell labeling revealed that iPSCs potentially mobilized to the damaged liver area. Taken together, iPSCs can effectively rescue experimental AHF and represent a potentially favorable cell source of cell-based therapy.",
author = "Chiou, {Shih Hwa} and Chiang, {Chih Hung} and Chang, {Ching Chih} and Huang, {Hui Chun} and Chen, {Yi Jen} and Tsai, {Ping Hsing} and Jeng, {Shaw Yeu} and Hung, {Shuen Iu} and Hsieh, {Jung Hung} and Huang, {Hsu Shan} and Lee, {Fa Yauh} and Lee, {Shou Dong}",
year = "2011",
doi = "10.1155/2011/219060",
language = "English",
volume = "2011",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury

AU - Chiou, Shih Hwa

AU - Chiang, Chih Hung

AU - Chang, Ching Chih

AU - Huang, Hui Chun

AU - Chen, Yi Jen

AU - Tsai, Ping Hsing

AU - Jeng, Shaw Yeu

AU - Hung, Shuen Iu

AU - Hsieh, Jung Hung

AU - Huang, Hsu Shan

AU - Lee, Fa Yauh

AU - Lee, Shou Dong

PY - 2011

Y1 - 2011

N2 - To date liver transplantation is the only effective treatment for end-stage liver diseases. Considering the potential of pluripotency and differentiation into tridermal lineages, induced pluripotent stem cells (iPSCs) may serve as an alternative of cell-based therapy. Herein, we investigated the effect of iPSC transplantation on thioacetamide- (TAA-) induced acute/fulminant hepatic failure (AHF) in mice. Firstly, we demonstrated that iPSCs had the capacity to differentiate into hepatocyte-like cells (iPSC-Heps) that expressed various hepatic markers, including albumin, -fetoprotein, and hepatocyte nuclear factor-3, and exhibited biological functions. Intravenous transplantation of iPSCs effectively reduced the hepatic necrotic area, improved liver functions and motor activity, and rescued TAA-treated mice from lethal AHF. 1,1 ′ -dioctadecyl-3,3, 3 ′,3 ′ -tetramethylindocarbocyanine perchlorate cell labeling revealed that iPSCs potentially mobilized to the damaged liver area. Taken together, iPSCs can effectively rescue experimental AHF and represent a potentially favorable cell source of cell-based therapy.

AB - To date liver transplantation is the only effective treatment for end-stage liver diseases. Considering the potential of pluripotency and differentiation into tridermal lineages, induced pluripotent stem cells (iPSCs) may serve as an alternative of cell-based therapy. Herein, we investigated the effect of iPSC transplantation on thioacetamide- (TAA-) induced acute/fulminant hepatic failure (AHF) in mice. Firstly, we demonstrated that iPSCs had the capacity to differentiate into hepatocyte-like cells (iPSC-Heps) that expressed various hepatic markers, including albumin, -fetoprotein, and hepatocyte nuclear factor-3, and exhibited biological functions. Intravenous transplantation of iPSCs effectively reduced the hepatic necrotic area, improved liver functions and motor activity, and rescued TAA-treated mice from lethal AHF. 1,1 ′ -dioctadecyl-3,3, 3 ′,3 ′ -tetramethylindocarbocyanine perchlorate cell labeling revealed that iPSCs potentially mobilized to the damaged liver area. Taken together, iPSCs can effectively rescue experimental AHF and represent a potentially favorable cell source of cell-based therapy.

UR - http://www.scopus.com/inward/record.url?scp=80053539421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053539421&partnerID=8YFLogxK

U2 - 10.1155/2011/219060

DO - 10.1155/2011/219060

M3 - Article

VL - 2011

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 219060

ER -